Akebia Therapeutics | AKBA - Despesas Operacionais





Despesas Operacionais Alterar Data
Acadia Pharmaceuticals USD 270.12M 2.55M 2026-06
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alnylam Pharmaceuticals USD 1.06B 160.97M 2026-06
Amgen USD 11.69B 6.9B 2026-06
Ardelyx USD 127.27M 7.15M 2026-03
Astellas Pharma JPY 455.56B 33.8B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Bayer EUR 10.04B 168M 2026-06
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Celltrion KRW 119.22B 21.46B 2026-03
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Exelixis USD 380.28M 20.8M 2026-06
Fresenius Medical Care EUR 4.32B 20.7M 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.93B 1.09B 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 960M 817M 2026-06
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pharma Mar EUR 51.01M 8.73M 2026-06
Prothena USD 25.29M 1.94M 2026-03
PTC Therapeutics USD 226.66M 19.64M 2026-03
Qiagen NV USD 393.64M 17.95M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 27.3M 5.78M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Vanda Pharmaceuticals USD -1.14B 1.6B 2025-12
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.45B 431.06M 2026-06